多中心研究比较10,369例有症状患者结肠胶囊内镜、结肠镜与CT结肠成像的诊断准确性
本研究纳入10,369例疑似结直肠癌且粪便免疫化学试验≤100 μg Hb/g的有症状患者,分别接受结肠胶囊内镜(4878例)、结肠镜(5025例)或CT结肠成像(466例)。结肠胶囊内镜对≥10 mm和6-9 mm息肉的患者灵敏度均为97%(配对、完整且肠道准备充分者),但完成率(74%)和肠道准备充分率(74%)低于结肠镜和CT结肠成像(均为88%)。结论认为结肠胶囊内镜安全准确,其「过滤功能」可补充现有结直肠诊断服务。
要点
- 结肠胶囊内镜对≥10 mm和6-9 mm息肉的患者灵敏度均为97%(配对、完整且准备充分者)。
- 结肠胶囊内镜完成率74%、肠道准备充分率74%,均低于结肠镜和CT结肠成像的88%。
- 结肠胶囊内镜在86%患者中有效发挥过滤功能,98.4%患者安全耐受。
核心结论
- 结肠胶囊内镜对结直肠疾病诊断安全且准确,在疑似结直肠癌路径中其「过滤功能」通过增加额外容量补充现有结直肠诊断服务。
研究设计与样本
- 多中心研究,招募同意接受结肠胶囊内镜、结肠镜或CT结肠成像的疑似结直肠癌路径且粪便免疫化学试验≤100 μg Hb/g粪便的患者,各队列按年龄、性别、症状和粪便免疫化学试验匹配。
- 共招募4878例结肠胶囊内镜患者、5025例结肠镜患者和466例CT结肠成像患者。
- 对结肠胶囊内镜后需结直肠内镜者进行配对比较,并记录临床结局。
主要发现
- 98.4%患者安全耐受结肠胶囊内镜。
- 结肠胶囊内镜在检查完整且准备充分时,在所有结直肠癌患者中识别出匹配的肿块病变。
- 结肠胶囊内镜检测到的≥10 mm和6-9 mm息肉多于结肠镜或CT结肠成像。
- 配对、完整且准备充分的结肠胶囊内镜与结肠镜相比,≥10 mm和6-9 mm息肉的患者灵敏度均为97%。
- 结肠胶囊内镜完成率74%、肠道准备充分率74%,均低于结肠镜和CT结肠成像的88%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: During the COVID-19 pandemic, NHS England introduced colon capsule endoscopy (CCE) at scale to support the recovery of endoscopy. Symptomatic patients referred with suspected colorectal cancer (CRC) and a faecal immunochemical test (FIT) ≤ 100 μg Hb/g faeces were offered CCE. AIMS: To evaluate the safety, diagnostic accuracy and utility of CCE in this setting. METHODS: Consenting patients, referred on a suspected CRC pathway with FIT ≤ 100 μg Hb/g faeces, were offered CCE, colonoscopy or CT colonography. Each cohort was to be age-, sex-, symptom- and FIT-matched. We performed a paired comparison of findings in those who required colorectal endoscopy after CCE and recorded clinical outcomes. RESULTS: We recruited 4878 patients for CCE, 5025 for colonoscopy and 466 for CT colonography patients. CCE was safely tolerated by 98.4% of patients. CCE identified a matched mass lesion in all patients with CRC when the examination was complete and adequately prepared. More polyps ≥ 10 mm and 6-9 mm were detected by CCE than by colonoscopy or CT colonography. Per-patient sensitivities for polyps ≥ 10 mm and 6-9 mm were 97% in those with a paired, complete and adequately prepared CCE than colonoscopy. Completion (74%) and bowel preparation adequacy rates (74%) were poorer than those of colonoscopy and CTC (both 88%). However, CCE usefully performed a filter function in 86% of patients. CONCLUSIONS: CCE is safe and accurate for the diagnosis of colorectal disease. In the suspected CRC pathway, its 'filter function' complements existing colorectal diagnostic services by creating additional capacity.
引用
- Turvill J, Haritakis M, Pygall S, et al. Multicentre Study of 10,369 Symptomatic Patients Comparing the Diagnostic Accuracy of Colon Capsule Endoscopy, Colonoscopy and CT Colonography. Aliment Pharmacol Ther. 2025. PMID: 40012235. doi:10.1111/apt.70046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。